Psychedelics Flashcards

1
Q

Describe how the relationship between serotonergic psychedelic / MDMA
administration and non-drug therapeutic approaches differs from other
approaches for PTSD and MDD

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What receptor do psychedelics bind to?

A

-5-HT2A agonist
-many targets but that is the big one

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MDMA MOA

A

-reversal of VMAT2: increase intracellular 5-HT
-Reversal of 5-HT through SERT
-Substrate / Releaser at
monoamine transporters (SERT
/ NET/ DAT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Metabolism of LSD

A

-metabolized by CYP2D6
-a little by 3A4, 1A2, 2C9, 2E1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Common dose of LSD

A

100-200 mcg
-elimination half life: 2.6 +/- 0.6 h
-subjective Effect Duration (200 mcg): 11.6 ±
1.7 h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Metabolism of Psilocybin

A

-undergos glucuronidation and other metabolism enzymes
-MAO-A
-UGT1A10 and 1A9
aldehyde dehydrogenase
-Few drug interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Metaboloism of DMT

A

-CYP2D6 and MAO-A
-little 2C19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

DMT dose range

A

-0.1-0.4 mg/kg IV
-30-50 mg inhaled
-Elimination half life 9-12 minutes
-Effect duration: 25 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Metabolism of 5-MeO-DMT

A

-CYP2D6 and MAO-A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Metabolism of MDMA

A

-CYP2D6
-CYP3A4
-MAO-A
-COMT
-most likely to cause drug interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Common MAO inhibitors

A

-Selegiline
-Tranylcypromine
-Isocarboxazid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Common strong CYP2D6 inhibitors

A

-Bupropion
-Fluoxetine
-Paroxetine
-Quinidine
-Terbinafine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Common moderate CYP2D6 inhibitors

A

-Duloxetine
-Cinacalcet
-Mirabegron
-Rolapitant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Common weak CYP2D6 inhibitors

A

-Escitalopram
-Fluvoxamine
-Sertraline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Haloperidol and psilocybin

A

-no effect
-increase the ‘dread of ego dissolution’: made them scared

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Risperidone and psilocybin

A

-reduced all the parameters of the APZ-OAV
-reduction in dread of ego
dissolution

17
Q

Lithium and psychedelics

A

-47% of lithium + psychedelics reports involved seizures
-serious seizure risk for this combo

18
Q

Drug interactions with MDMA

A

-MAOIs and MDMA
-dangerous elevation in synaptic serotonin
-causes most deaths

19
Q

Bupropion and MDMA

A

-increase risk of seizure
-stimulant toxicity
-Serotonin syndrome

20
Q

(Citalopram, fluoxetine, paroxetine) and MDMA

A

-increase drug effects by 30-80%
-physiological effects increase 6-14%

21
Q

Duloxetine and MDMA

A

-increase heart rate and BP
-effect on mood was significantly reduced by duloxetine

22
Q

Chronic Psychedelic Use and Drug-
Induced Valvular Heart Disease
Considerations

A

-chronic 5-HT2B agonism is a concern with microdosing

23
Q
A